4 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Nivolumab - Autoimmune Diseases, Non-small Cell Lung Cancer | Phase 1 | Terminated | Alliance Foundation Trials, LLC. | 7 | 2019-06-27 | 2023-02-15 |
| Ustekinumab for the Treatment of Giant Cell Arteritis Ustekinumab, Prednisone - Giant Cell Arteritis, Temporal Arteritis | Phase 1 / Phase 2 | Terminated | Massachusetts General Hospital | 13 | 2016-12-01 | 2020-06-12 |
| Stem Cell Transplantation in Ocular Lesions of Behcet's Disease Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome | Phase 1 | Terminated | Tehran University of Medical Sciences | 5 | 2007-12-01 | 2015-11-10 |
| Hematopoietic Stem Cell Support in Vasculitis Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant, Cyclophosphamide - Vasculitis | Phase 1 | Terminated | Northwestern University | 7 | 2003-08-01 | 2018-08-02 |
Giant Cell Arteritis (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Behcet Syndrome (1) · Carcinoma, Non-Small-Cell Lung (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Lupus Erythematosus, Systemic (1) · Multiple Sclerosis (1) · Papilledema (1) · Polymyalgia Rheumatica (1) · Psoriasis (1) · Retinal Vasculitis (1) · Retinitis (1)
Cardiovascular Diseases (4) · Vascular Diseases (4) · Nervous System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Arteritis (2) · Autoimmune Diseases of the Nervous System (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Immune System Diseases (2) · Vasculitis, Central Nervous System (2) · Arthritis (1)
Alemtuzumab (1) · Cyclophosphamide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Mesna (1) · Nivolumab (1) · Prednisone (1) · Tacrolimus (1) · Ustekinumab (1) · fludarabine (1) · fludarabine phosphate (1) · thymoglobulin (1)
Alliance Foundation Trials, LLC. (1) · Massachusetts General Hospital (1) · Northwestern University (1) · Tehran University of Medical Sciences (1)
United States (3) · Iran (1)
Behrouz Nikbin, MD (1) · Fereydoun Davatchi, MD (1) · Hormoz Shams, MD (1) · Richard Burt, MD (1)